STK11 and lung adenocarcinoma: In animal studies of lung adenocarcinoma, it has been found that the inactivation or mutation of STK11 will be related to the change of the tumor microenvironment and the decrease of cytotoxic CD8+ cell infiltration, which will lead to the separation of the tumor from the body’s immune monitoring.